Interferons in precancer and cancer prevention: Where are we?

Journal of Interferon and Cytokine Research

Volumn 16, Issue 5, 1996, Pages 339-346

  Tanneberger, Stephan ^a  

^a Associazione Nazionale Tumori   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; BIOLOGICAL RESPONSE MODIFIER; CYTOCHROME P450; ETHOXYRESORUFIN DEETHYLASE; INTERFERON; PHENAZONE; RECOMBINANT ALPHA2B INTERFERON; THEOPHYLLINE DERIVATIVE; UNSPECIFIC MONOOXYGENASE;

BLADDER CARCINOGENESIS; CANCER IMMUNOLOGY; CANCER PREVENTION; CLINICAL TRIAL; DIAGNOSIS; DRUG MECHANISM; GENOTOXICITY; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; IMMUNOPROPHYLAXIS; META ANALYSIS; PRECANCER; PRIORITY JOURNAL; REVIEW;

EID: 0029914334     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1996.16.339     Document Type: Review

References (4)

1. SPORN, M. (1991). Carcinogenesis and cancer: different perspectives on the same disease. Cancer Res. 51, 6215-6218.
2. ZUBROD, C.G., SCHEPARTZ, S., LEITER, J., ENDICOTT, K.M., CARRESE, L.M., and BAKER, C.G. (1966). The chemotherapy program of the National Cancer Institute: history, analysis and plans. Cancer Chemother. Rep. 50, 349-540.
3. GREENBERG, D.S. (1991). A sober anniversary of the "war on cancer." Lancet 338, 1582-1583.
4. TANNEBERGER, S. (1992). Timo, fattori timici e cancro. In: Progressi in Oncologia Clinica. G. Robustelli della Cuna (ed.). Pavia: EDIMES.